Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Women with excessive body hair often have higher male hormones and related health issues.

Combining Hebai formula with minoxidil improves hair growth and reduces hair loss better than minoxidil alone.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

Cetosomal minoxidil is safer and as effective as alcohol-based minoxidil for male hair loss treatment.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

Goats with BSE or scrapie show varying symptoms, and using only clinical signs may not detect all scrapie cases.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

N-WASP is essential for normal hair growth in mice.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Younger patients with severe alopecia areata often have nail problems.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

New regenerative therapies show promise for treating hair loss.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

PRP and microneedling both effectively improve hair growth and thickness for treating hair loss.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Injecting stem cells from a patient's own fat can improve hair growth in women with hair loss.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.